Physician
Pediatric Hematology & Oncology
Dr. Bruce C. Bostrom, MD
|
|
Give Review
Bruce C. Bostrom works in the field of Pediatric Hematology & Oncology. He graduated from Mayo Medical School. Mayo Medical School is ranked 27/42 in Research/PrimaryCare. Bruce Bostrom is a published doctor and has 97 publications published. The lastest was: 'Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children''s Cancer Group Study.'
Publications
- Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia-Comparison among Different Treatment Strategies.
- Survivors of standard risk Acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: A report from the Children'...
- Adherence to oral 6-mercaptopurine in African American and Asian children with Acute lymphoblastic leukemia: a Children's Oncology Group study.
- The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with Acute lymphoblastic leukemia.
- A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acu...
- Safety and Efficacy of Metformin for Therapy-induced Hyperglycemia in Children With Acute Lymphoblastic Leukemia.
- Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly.
- Successful management of extreme hypertriglyceridemia from pegaspargase with omega-3.
- Bortezomib with chemotherapy is highly active in advanced B-precursor Acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia Lymphoma (TACL) Study.
- Escalating intravenous methotrexate improves event-free survival in children with standard-risk Acute lymphoblastic leukemia: a report from the Children's Oncology Group.
- Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood Acute lymphoblastic leukemia (ALL): a report from the therapeutic advances i...
- Effective Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole once a day twice a week.
- Characteristics of patients with TEL-AML1-positive Acute lymphoblastic leukemia with single or multiple fusions.
- Bone marrow transplantation versus prolonged intensive chemotherapy for children with Acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months ...
- Intravenous 6-mercaptopurine decreases salvage after relapse in childhood Acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
- Systemic methotrexate exposure is greater after intrathecal than after oral administration.
- A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard...
- Abnormalities of chromosome bands 15q13-15 in childhood Acute lymphoblastic leukemia.
- Clinical collection and use of peripheral blood stem cells in pediatric patients.
- G-CSF or GM-CSF to ameliorate chemotherapy-induced cytopenia.
- Collection and use of peripheral blood stem cells in very small children.
- Inhibitory effect of adenosine dialdehyde on in situ murine neuroblastoma growth.
- Relapse after bone marrow transplantation for Acute leukaemia.
- Mucositis and alpha-streptococcal sepsis in bone marrow transplant recipients.
- Streptococcal sepsis in bone marrow transplant patients.
- The value of bone marrow trephine biopsy in the diagnosis of metastatic neuroblastoma.
- Gefitinib therapy for life-threatening laryngeal papillomatosis.
- Elevation of cerebrospinal fluid catecholamine metabolites in patients with intracranial tumors of neuroectodermal origin.
- Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells.
- Elevation of lumbar cerebrospinal fluid catecholamine metabolites in patients with cranial and/or intracranial metastatic neuroblastoma.
- Severe ileus from cisplatin and vinblastine infusion in neuroblastoma.
- An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for Leukemia or genetic disease.
- Hodgkin Disease in a child with fetal alcohol-hydantoin syndrome.
- Morphoproteomics and bortezomib/dexamethasone-induced response in relapsed Acute lymphoblastic leukemia.
- Propofol use in pediatric patients with severe Cancer pain at the end of life.
- Apparent compatibility of methotrexate and vancomycin.
- Cisplatin, vinblastine, and bleomycin (CVB) therapy for relapsed disseminated neuroblastoma.
- Depot characteristics and biodistribution of interleukin-2 liposomes: importance of route of administration.
- Epstein-Barr-virus-related post-bone-marrow-transplant lymphoproliferative Disease: association with cytomegalovirus infection and Down syndrome donor marrow.
- Role of busulfan pharmacokinetics on outcome after bone marrow transplantation for Acute myelogenous leukemia.
- Clonogenicity of circulating neuroblastoma cells: implications regarding peripheral blood stem cell transplantation.
- A phase 1 study of Combotox in pediatric patients with refractory B-lineage Acute lymphoblastic leukemia.
- Relationship of plasma pharmacokinetics of high-dose oral busulfan to the outcome of allogeneic bone marrow transplantation in children with thalassemia.
- Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with Acute lymphoblastic leukemia in first bone marrow relapse: a...
- Deletion of 7p or monosomy 7 in pediatric Acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children''s Cancer Group.
- Plasma pharmacokinetics of high-dose oral busulfan in children and adults undergoing bone marrow transplantation.
- Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for Acute non-lymphoblastic leukemia in first remission.
- Autologous peripheral blood cell transplantation in the treatment of advanced neuroblastoma.
- Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory Acute lymphoblastic leukemia.
- Pleuropulmonary blastoma: a marker for familial Disease.
- Busulfan pharmacokinetics do not predict relapse in Acute myeloid leukemia.
- Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse.
- In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in Acute lymphoblastic leukemia patients receiving purged autografts.
- One course versus two courses of antithymocyte globulin for the treatment of severe aplastic Anemia in children.
- Antithymocyte globulin, cyclosporine, and prednisone for the treatment of severe aplastic Anemia in children. A pilot study.
- Therapy-related myelodysplastic syndrome and Acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy.
- Bone marrow transplantation for Acute nonlymphocytic leukemia in first remission: analysis of prognostic factors.
- Successful reinduction of patients with Acute lymphoblastic leukemia who relapse following bone marrow transplantation.
- Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children''s Cancer Group Study.
- Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group study.
- Bone marrow transplantation for advanced Acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
- Bone marrow transplantation for Acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cy...
- A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood Acute lymphoblastic leukemia.
- Allogeneic and autologous bone marrow transplantation for Acute lymphoblastic leukemia.
- Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation.
- Cellular pharmacology of 6-mercaptopurine in Acute lymphoblastic leukemia.
- Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood Acute lymphoblastic leukemia: a Children's Cancer Group Study.
- Treatment of refractory and relapsed Hodgkin's Disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support.
- Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood Acute lymphoblastic leukemia: a report from the Children's Cancer Group.
- Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood Acute lymphoblastic leukemia: a report from the children's cancer group.
- Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.
- Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatmen...
- Outcome for children treated for relapsed or refractory Acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.
- Outcome of patients treated for relapsed or refractory Acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.
- A comparison of red blood cell thiopurine metabolites in children with Acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pedia...
- Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
- Pharmacokinetics of fluconazole in immune-compromised children with Leukemia or other hematologic diseases.
- Allogeneic bone marrow transplantation for Acute nonlymphocytic leukemia in first remission.
- A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguani...
- Reversed-phase high-performance liquid chromatographic approach to determine total lymphocyte concentrations of 6-thioguanine, methylmercaptopurine and methylthioguani...
- Association of chromosome arm 9p abnormalities with adverse risk in childhood Acute lymphoblastic leukemia: A report from the Children's Cancer Group.
- High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
- Early response to therapy and outcome in childhood Acute lymphoblastic leukemia: a review.
- Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with Acute lymphoblastic leukemia: a Children''s Cancer Group initiative.
- Treatment of childhood lymphangiomas with interferon-alpha.
- Clinical features and treatment outcome of childhood T-lineage Acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: ...
- Prospective, randomized, double-blind, placebo-controlled comparison of metoclopramide and ondansetron for prevention of posttonsillectomy or adenotonsillectomy emesis.
- Juvenile xanthogranuloma: forms of Systemic disease and their clinical implications.
- Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with Acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes).
- Clinical significance of deletions of chromosome arm 6q in childhood Acute lymphoblastic leukemia: a report from the Children''s Cancer Group.
- Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with Acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NC...
- Duration of hospitalization as a measure of cost on Children's Cancer Group Acute lymphoblastic leukemia studies.
- Abnormalities of chromosome bands 13q12 to 13q14 in childhood Acute lymphoblastic leukemia.
- Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk Acute lymphoblastic leukemia: a report from the...
- Double-delayed intensification improves event-free survival for children with intermediate-risk Acute lymphoblastic leukemia: a report from the Children''s Cancer Group.
- Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk Acute lymphoblastic leukemia: a collaborativ...
Schools
Mayo Medical School
Chldns Hospital Med Center
University Of Minnesota
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
University of Minnesota at Fairview -
Cincinnati Children's Hospital Medical Center -
University Hospital - University of Cincinnati College of Medicine -
Mayo Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Deneen D. Vojta, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Weston P. Miller IV, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce R. Blazar, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Margaret A. Kurth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan C. Simonton, MD |
|
|
Dr. Jawhar Rawwas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jakub Tolar, MD
This Doctor is OpenDoctor Recommended.
|